Skip to content
10-K

Annual Report

AMERICAN ORIENTAL BIOENGINEERING INC

0001019687-13-002302

← back to feed
Filed
Jun 11, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Jun 10, 2013 36.42M sh
Shares Diluted FY 2012 · Dec 31, 2012 38.3M sh
Shares Diluted FY 2012 · Dec 31, 2011 37.42M sh
Shares Diluted FY 2012 · Dec 31, 2010 37.86M sh
Stock Repurchased FY 2012 · Dec 31, 2012 $1.27M
Stock Repurchased FY 2012 · Dec 31, 2011 $800K
Capex FY 2012 · Dec 31, 2012 $18.66M
Capex restated FY 2012 · Dec 31, 2011 $36.4M
Capex restated FY 2012 · Dec 31, 2010 $6.06M
Operating Cash Flow FY 2012 · Dec 31, 2012 −$46.45M
Operating Cash Flow FY 2012 · Dec 31, 2011 $29.96M
Operating Cash Flow FY 2012 · Dec 31, 2010 $8.21M
Long Term Debt FY 2012 · Dec 31, 2012 $554.59K
Short Term Debt FY 2012 · Dec 31, 2012 $64.81K
Cash And Equivalents FY 2012 · Dec 31, 2012 $7.1M
Cash And Equivalents FY 2012 · Dec 31, 2011 $52.63M
Cash And Equivalents FY 2012 · Dec 31, 2010 $94.57M
Cash And Equivalents FY 2012 · Dec 31, 2009 $91.13M
Stockholders Equity FY 2012 · Dec 31, 2012 $327.59M
Stockholders Equity FY 2012 · Dec 31, 2011 $381.7M
Current Liabilities FY 2012 · Dec 31, 2012 $106.21M
Current Liabilities restated FY 2012 · Dec 31, 2011 $168.63M
Total Liabilities FY 2012 · Dec 31, 2012 $118.72M
Total Liabilities FY 2012 · Dec 31, 2011 $183.82M
Current Assets FY 2012 · Dec 31, 2012 $95.45M
Current Assets FY 2012 · Dec 31, 2011 $195.91M
Total Assets FY 2012 · Dec 31, 2012 $446.31M
Total Assets FY 2012 · Dec 31, 2011 $564.98M
Eps Diluted FY 2012 · Dec 31, 2012 −$1.56
Eps Diluted FY 2012 · Dec 31, 2011 −$1.80
Eps Diluted FY 2012 · Dec 31, 2010 $0.37
Eps Basic FY 2012 · Dec 31, 2012 −$1.56
Eps Basic FY 2012 · Dec 31, 2011 −$1.80
Eps Basic FY 2012 · Dec 31, 2010 $0.38
Sga Expense FY 2012 · Dec 31, 2012 $49.73M
Sga Expense FY 2012 · Dec 31, 2011 $51.35M
Sga Expense FY 2012 · Dec 31, 2010 $66.44M
Rd Expense FY 2012 · Dec 31, 2012 $6.25M
Rd Expense FY 2012 · Dec 31, 2011 $12.66M
Rd Expense FY 2012 · Dec 31, 2010 $15.37M
Net Income FY 2012 · Dec 31, 2012 −$59.71M
Net Income FY 2012 · Dec 31, 2011 −$67.45M
Net Income FY 2012 · Dec 31, 2010 $14.09M
Operating Income FY 2012 · Dec 31, 2012 −$86.33M
Operating Income FY 2012 · Dec 31, 2011 −$43.12M
Operating Income FY 2012 · Dec 31, 2010 $30.37M
Gross Profit FY 2012 · Dec 31, 2012 $44.36M
Gross Profit FY 2012 · Dec 31, 2011 $99.75M
Gross Profit FY 2012 · Dec 31, 2010 $157.76M
Cost Of Revenue FY 2012 · Dec 31, 2012 $100.74M
Cost Of Revenue FY 2012 · Dec 31, 2011 $112.94M
Cost Of Revenue FY 2012 · Dec 31, 2010 $148.19M
Revenue FY 2012 · Dec 31, 2012 $145.1M
Revenue FY 2012 · Dec 31, 2011 $212.69M
Revenue FY 2012 · Dec 31, 2010 $305.94M